Lonza to Cut Jobs at Swiss Manufacturing Site in Savings Bid

Lock
This article is for subscribers only.

Lonza Group AG said it plans to cut 500 jobs, mostly at a Swiss site that manufactures chemical intermediates and active pharmaceutical ingredients, and is evaluating further job cuts worldwide.

Lonza is seeking deeper cost savings from its global manufacturing base and may be able to give details next year, Chief Executive Officer Richard Ridinger said on a call, adding that the Basel-based company may comment at a later date on streamlining management.